SCHEMBL5369726

SCHEMBL5369726

CC(C)(C)c1cc(C=O)cc(I)c1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.46
MAOB P27338 3/20 0.46
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
LMNA P02545 3/20 0.37
FEN1 P39748 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 2/20 0.36
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CDK4 P11802 1/20 0.36
CCNB1 P14635 1/20 0.36
CCND1 P24385 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
NPC1 O15118 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5366582 0.90 MAOA (0.51) MAOAMAOBRXRARXRBRXRG
SCHEMBL5368735 0.84 MAOA (0.46) MAOAMAOBRXRARXRBRXRG
SCHEMBL5365873 0.84 MAOA (0.46) MAOAMAOBRXRARXRBRXRG
SCHEMBL5367770 0.80 MAOA (0.42) MAOAMAOBHPGDRAB9ANPC1
SCHEMBL9692061 0.80 ALDH1A1 (0.52) MAOAMAOBTDP1ALDH1A1KDM4E
SCHEMBL1406410 0.79 MAOB (0.44) MAOAMAOBRXRARXRBRXRG
SCHEMBL3235715 0.77 MAOA (0.52) MAOAMAOBRXRARXRBRXRG
SCHEMBL1406357 0.76 LMNA (0.62) RXRARXRBRXRGLMNAHPGD
SCHEMBL5366175 0.76 ERBB2 (0.51) MAOAMAOBLMNAHPGDTDP1
SCHEMBL5370373 0.75 MCL1 (0.41) HPGDTDP1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed
US-6133305-A PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISORDERS SUCH AS CANCER SUGEN, INC. (US) 2000-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK MAOA 1231/4885MAOB 867/4885RXRA 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.